Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug...

Related Keywords

Richa Kumari ,Kiki Patel ,James Levine ,Nasdaq ,Gilmartin Group ,Prnewswire Cardiff Oncology Inc ,Cardiff Oncology Inc ,Taft Communications ,Cardiff Oncology ,Nasdaq Listing Rule ,Oncology Contact ,